toxic or drug-related embryofetopathy fetal carbamazepine syndrome https://github.com/monarch-initiative/mondo/issues/6876 https://www.malacards.org/card/fetal_carbamazepine_syndrome MONDO:0018263 Orphanet:370076 UMLS:C0432370 MEDGEN:609479 A drug-related embryofetopathy that can occur when an embryo/fetus is exposed to carbamazepine and that is characterized by facial dysmorphism, with some similarities to that seen in fetal valproate syndrome (see this term), such as epicanthal folds, upward slanting palpebral fissures, short nose, micrognathia and malar hypoplasia, as well as nail dysplasia and major anomalies including cleft lip/palate, neural tube defects and cardiac anomalies. In utero exposure to carbamazepine, in combination with valproate, has been associated with significant developmental delay (particularly affecting verbal intelligence) and a high rate of congenital anomalies. ICD9:760.8 SCTID:254249002